CGON Overview

Company Profile

Related stocks

MANE • United States

Veradermics, Incorporated

130.9 USD

5.47B USD

COGT • United States

Cogent Biosciences, Inc.

31 USD

5.38B USD 1Y +93.1%

PTCT • United States

PTC Therapeutics, Inc.

64.7 USD

5.4B USD 1Y -3%

DNTH • United States

Dianthus Therapeutics, Inc.

82.37 USD

4.5B USD 1Y +137.2%

CAI • United States

Caris Life Sciences, Inc.

29.7 USD

8.39B USD 1Y -16.5%

EWTX • United States

Edgewise Therapeutics, Inc.

39.06 USD

4.24B USD 1Y +155.6%

IONS • United States

Ionis Pharmaceuticals, Inc.

45.28 USD

7.52B USD 1Y -38.1%

ERAS • United States

Erasca, Inc.

16.03 USD

5.61B USD 1Y +536.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

62.4% p.a.

Max Drawdown (3Y)

-67.5%

Sharpe Ratio (3Y)

0.31

Beta Factor

0.28

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.